Version 2.76

Term Description

This panel aides in the determination of compliance or identify illicit stimulant drug use. The panel detects stimulants which stimulate the central nervous system activity and, in part, suppress the appetite. Amphetamine and methamphetamine are also prescription drugs used in the treatment of narcolepsy and attention-deficit disorder/attention-deficit hyperactivity disorder (ADHD). Methylphenidate is another stimulant used to treat ADHD. Phentermine is indicated for the management of obesity. All of the other amphetamines (e.g., methylenedioxymethamphetamine: MDMA) are Drug Enforcement Administration (DEA) scheduled Class I compounds. Physiological symptoms associated with very high amounts of ingested amphetamine or methamphetamine include elevated blood pressure, dilated pupils, hyperthermia, convulsions, and acute amphetamine psychosis.

If a stimulant or its corresponding metabolite is identified (present), it indicates that the patient has used the respective stimulant in the recent past (typically 1-3 days). The absence of the expected stimulant or its metabolites may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted or adulterated urine, or limitations of testing. The concentration of the drug must be greater than or equal to the cutoff to be reported as present.
Source: Regenstrief LOINC

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
99107-5 Stimulants drug panel - Urine by Screen method
Indent19554-5 Methamphetamine [Presence] in Urine by Screen method
Indent19674-1 Phentermine [Presence] in Urine by Screen method
Indent19343-3 Amphetamine [Presence] in Urine by Screen method
Indent19659-2 Phencyclidine [Presence] in Urine by Screen method
Indent19577-6 Methylphenidate [Presence] in Urine by Screen method
Indent19568-5 Methylenedioxymethamphetamine [Presence] in Urine by Screen method
Indent59844-1 Methylenedioxyethylamphetamine [Presence] in Urine by Screen method
Indent19565-1 Methylenedioxyamphetamine [Presence] in Urine by Screen method

Fully-Specified Name

Stimulants drug panel

Additional Names

Short Name
Stimulants drug panel Ur Scn
Display Name
Stimulants drug panel Screen (U)
Consumer Name Alpha Get Info
Stimulants drug panel, Urine

Example Answer List: LL744-4

Source: Regenstrief Institute
Answer Code Score Answer ID
Detected LA11882-0
Not detected LA11883-8

Basic Attributes

First Released
Version 2.72
Last Updated
Version 2.72
Order vs. Observation
Panel Type

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Panel de drogas estimulantes:Propiedades mixtas (sólo paneles):Punto temporal:Orina:-:Cribado toxicológico
fr-FR French (France) Stimulants panel:-:Ponctuel:Urine:-:Dépistage
it-IT Italian (Italy) Farmaci stimolanti, panel:-:Pt:Urine:-:Screening
Synonyms: Livelli farmacologici e tossicologia Panel farmaci stimolanti Punto nel tempo (episodio) Screening tossicologico Set di prescrizione per livelli farmacologici e to
nl-NL Dutch (Netherlands) stimulerende middelen panel:-:moment:urine:-:screening
Synonyms: stimulerende drugs
zh-CN Chinese (China) 兴奋剂类药物组套:-:时间点:尿液:-:毒理学筛查试验
Synonyms: 兴奋剂类(兴奋剂、刺激物、刺激剂)药物(毒品)组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目) 兴奋药;刺激剂 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.药物/毒理学试验;组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目).药物/毒理学;医嘱组.药物与毒理学;医嘱组.药物与毒理学试验;医嘱组类.药物/毒理学;医嘱组类.药物/毒理学试验;医嘱组类.药物与毒理学;医嘱组类.药物与毒理学试验;实验室医嘱组类.药物/毒理学;实验室医嘱组类.药物/毒理学试验;实验室医嘱组类.药物与毒理学;实验室医嘱组类.药物与毒理学试验;药物与毒理学医嘱组;药物与毒理学医嘱组类 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 尿;小便;下泉 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 毒品 毒品;麻醉药;麻醉品;麻药;兴奋剂;药品 毒品类 筛查 筛查方法;筛查法;筛查试验 筛查试验 筛选试验 组 组合 组合医嘱 组合类 组套 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类 过筛 过筛试验

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup$lookup?system=
Questionnaire definition